With one of the largest research peptide suppliers closing its doors, laboratories and independent researchers are reassessing their supply chains. Here's what happened and where the market is heading.
Part of the PeptidesATX Research Hub
Peptide Sciences, once one of the most well-known names in the research peptide space, has voluntarily shut down operations. The company had built a sizable customer base over the years by offering a wide catalog of synthetic peptides for laboratory use, and its closure caught many researchers and institutions off guard.
While Peptide Sciences did not issue a single definitive public statement explaining the shutdown, the closure came during a period of heightened regulatory attention on the research peptide industry. The FDA has increased its scrutiny of peptide suppliers, particularly those whose products may have been used outside of legitimate research contexts. This regulatory pressure, combined with evolving market conditions, appears to have contributed to the company's decision to cease operations.
The immediate impact was felt by the thousands of laboratories and independent researchers who relied on Peptide Sciences as their primary or sole supplier. Orders were halted, existing accounts were closed, and researchers were left to find alternative sources for the compounds central to their ongoing studies.
Despite the closure of a major supplier, the demand for research peptides has not slowed down. If anything, the market continues to expand as scientific interest in peptide-based research intensifies across multiple disciplines.
Several factors are driving this sustained growth:
The closure of Peptide Sciences has not diminished this demand—it has simply redistributed it across the remaining supplier landscape.
With a major supplier out of the picture, laboratories selecting a new peptide source are applying rigorous criteria. The research community has become increasingly sophisticated in evaluating supplier quality, and the bar for entry continues to rise.
The most critical factor for any research peptide supplier is the ability to demonstrate compound purity through independent, third-party testing. Reputable suppliers submit every batch to HPLC (High-Performance Liquid Chromatography) analysis and mass spectrometry to verify both purity and molecular identity. Research-grade peptides should consistently meet or exceed 98% purity thresholds.
A Certificate of Analysis (COA) is not optional—it is a baseline requirement. Labs expect batch-specific COAs that include HPLC chromatograms, mass spectrometry data, purity percentages, and testing dates. COAs should be readily accessible, not something a customer has to request repeatedly or wait weeks to receive. To understand what a proper COA should contain, see our guide to peptide purity testing and COA evaluation.
Peptide integrity depends on proper handling during transit. Temperature-sensitive compounds require appropriate packaging, and domestic shipping within the United States avoids the delays, customs issues, and quality risks associated with international sourcing. Researchers need their compounds to arrive quickly and in proper condition.
Legitimate peptide suppliers clearly label all products as intended for research use only. This means no therapeutic claims, no dosage recommendations for human use, and no marketing language that implies these compounds are drugs or supplements. Compliance with research-use-only standards is both a legal requirement and a signal of supplier credibility.
When a researcher has a question about a specific lot, needs documentation for an institutional review, or encounters an issue with an order, they need a supplier who responds promptly. The days of submitting a support ticket and waiting a week for a reply are over. Modern research suppliers maintain direct communication channels and treat customer inquiries as priorities.
In the months since Peptide Sciences closed, the supplier landscape has shifted. Rather than consolidating around a single dominant player, the market has moved toward a more distributed model where smaller, quality-focused suppliers are absorbing the demand that Peptide Sciences once served.
This shift has actually been beneficial for researchers in several ways. Smaller suppliers tend to offer more personalized service, faster response times, and greater flexibility in fulfilling specific research needs. Many also maintain tighter quality control because they process fewer, more manageable batch volumes.
When evaluating alternatives, researchers should prioritize suppliers that meet the criteria outlined above: third-party testing, transparent COAs, domestic shipping, and clear research-use-only positioning. It is also worth evaluating whether a supplier carries the specific compounds relevant to your research program, as catalog breadth varies significantly across the market.
PeptidesATX is one supplier that has emerged as a trusted option for research laboratories. Based in Austin, Texas, PeptidesATX offers a focused catalog of research-grade peptides with batch-specific COAs, third-party HPLC testing, and fast domestic shipping. Every compound is sold exclusively for research use and meets the purity standards that serious laboratories require. For a deeper look at how to evaluate any peptide vendor, see our vendor evaluation guide.
For labs transitioning from Peptide Sciences, the following compounds represent some of the most actively studied peptides in current research programs:
A triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. Retatrutide has generated significant research interest due to its unique multi-receptor mechanism, which is being studied for its effects on metabolic pathways. It represents a new generation of multi-agonist compounds that go beyond the dual-agonist approach. Learn more in our retatrutide research guide.
A dual GIP/GLP-1 receptor agonist that has been extensively studied in clinical trials. Tirzepatide is one of the most well-documented peptides in metabolic research and continues to be a staple in laboratories investigating incretin-based mechanisms. See our tirzepatide research overview for more detail.
A 15-amino-acid synthetic peptide derived from human gastric juice protein. BPC-157 is widely studied in preclinical models for its observed interactions with growth factor pathways, nitric oxide systems, and angiogenic mechanisms. It remains one of the most popular research peptides by volume. Our BPC-157 research guide covers its molecular structure and laboratory applications in detail.
A synthetic fragment of thymosin beta-4, TB-500 is studied for its role in cellular migration and cytoskeletal organization. Researchers frequently investigate TB-500 alongside BPC-157 due to their complementary mechanisms in preclinical models. Read more in our TB-500 research guide.
A naturally occurring copper-binding tripeptide that has been the subject of research into tissue remodeling, gene expression modulation, and antioxidant activity. GHK-Cu is unique among research peptides due to its metal-binding properties and the breadth of biological activities observed in laboratory settings. Our GHK-Cu research guide provides a comprehensive overview.
Peptide Sciences voluntarily ceased operations. The company did not publicly disclose a single reason for the closure, but the decision came amid increasing regulatory scrutiny of the research peptide industry and shifting market dynamics. The shutdown left many research laboratories searching for alternative suppliers.
Research laboratories are sourcing peptides from other established suppliers that offer third-party purity testing, batch-specific Certificates of Analysis (COAs), and research-use-only compliance. PeptidesATX is one such supplier, offering research-grade peptides with ≥98% purity verification and transparent quality documentation.
Key factors include: third-party HPLC and mass spectrometry testing, batch-specific Certificates of Analysis, transparent sourcing and manufacturing practices, reliable domestic shipping, proper research-use-only labeling, and responsive customer support. Avoid suppliers that make therapeutic or medical claims about their compounds.
Research peptides sold for laboratory and scientific research purposes remain legal to purchase in the United States. They must be clearly labeled as "for research use only" and are not intended for human or veterinary use. Buyers should ensure their supplier maintains proper research-use-only compliance and documentation.
PeptidesATX offers research-grade peptides with third-party testing, batch-specific COAs, and fast domestic shipping from Austin, TX.
Browse Research Peptides View Certificates of AnalysisDisclaimer: This compound is intended for laboratory research use only. It is not approved for human or veterinary use.